Pons
PrivateLast Round
Accelerator
Sep 23, 2024
Total Funding Raised
$520,800
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pons is a healthcare technology company that develops device-agnostic AI software to improve ultrasound imaging by providing advanced visual insights and enhancing scan resolution, tissue contrast, and noise reduction through deep learning algorithms without the need for costly new hardware.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pons Comparables
Compare Pons with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioticsAI | 82% | |
| SmartAlpha | 80% | |
| Koios Medical | 78% |
Pons Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 23, 2024 | ||||
| Grant | Aug 21, 2024 | ||||
| Grant | Jun 21, 2024 | ||||
| Seed | Dec 19, 2022 | ||||
| Accelerator | Nov 30, 2022 | ||||
Accelerator | Mar 1, 2022 |
Pons Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AgeTech Collaborative | Grant |
| H7 BioCapital | Accelerator |
| Unlock Capital | Accelerator |
| SOSV | Seed, Accelerator |
| HAX | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 2113% MoM.
- Apr 16, 2026
Monthly visitors grew 107% MoM, reaching 2.1K.
Recent news
Latest coverage and updates
- has_revenueSep 5, 2026
PONS has revenue of $1.24M.
Pons Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pons's valuation, stock price, and market status.
Is Pons a public or private company?
Pons is a private company.
What is the current stock price of Pons?
Pons is a private company with no public stock price. No recent secondary market data is available.
How much is Pons worth (valuation)?
Valuation information for Pons is not publicly available.
Can I buy Pons stock?
Pons shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pons's last funding round?
Pons's most recent funding round was Accelerator on September 23, 2024.
Who are the main investors in Pons?
Key investors in Pons include H7 BioCapital, Unlock Capital, HAX.
Will Pons IPO soon?
No public IPO plans have been announced for Pons.
How can I track Pons secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pons's secondary market activity and sign up for updates.